Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimics

Journal of Pathology: Clinical Research

Volumn 1, Issue 2, 2015, Pages 113-123

  Presneau, Nadège ^a,g   Baumhoer, Daniel ^b,g   Behjati, Sam ^c   Pillay, Nischalan ^d   Tarpey, Patrick ^c   Campbell, Peter J ^c   Jundt, Gernot ^b   Hamoudi, Rifat ^a,h   Wedge, David C ^c   Loo, Peter Van ^c,e   Hassan, A Bassim ^f   Khatri, Bhavisha ^d   Ye, Hongtao ^d   Tirabosco, Roberto ^d   Amary, M Fernanda ^d   Flanagan, Adrienne M ^a,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g UNIVERSITY OF WESTMINSTER   (United Kingdom)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Giant cell granuloma; Giant cell tumour of bone; H3F3A; H3F3B; Malignant giant cell tumour of bone; Solid variant of aneurysmal bone cyst; USP6

Indexed keywords

ISOCITRATE DEHYDROGENASE 1; ISOCITRATE DEHYDROGENASE 2;

ADULT; ARTICLE; BONE CYST; CANCER CLASSIFICATION; CHONDROBLASTOMA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EXOME; FEMALE; FIBROMA; GENE MUTATION; GENE SEQUENCE; H3F3A GENE; HUMAN; HUMAN TISSUE; IDH1 GENE; IDH2 GENE; MALE; MUTATIONAL ANALYSIS; ONCOGENE; OSTEOCLAST; OSTEOCLASTOMA; PRIORITY JOURNAL; TP53 GENE; USP6 GENE; YOUNG ADULT;

EID: 84937516906     PISSN: None     EISSN: 20564538     Source Type: Journal    
DOI: 10.1002/cjp2.13     Document Type: Article

References (27)

1. Athanasou NA, Bansal M, Forsyth R, et al. Giant cell tumour of bone. In WHO Classification of Tumours of Soft Tissue and Bone, (4th edn), Fletcher CDM, Bridge JA, Hogendoorn PCW, et al. (eds). IARC Press: Lyon, France, 2013; 321-324.
2. Behjati S, Tarpey PS, Presneau N, et al. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet 2013; 45: 1479-1482.
3. Joseph CG, Hwang H, Jiao Y, et al. Exomic analysis of myxoid liposarcomas, synovial sarcomas, and osteosarcomas. Genes Chromosomes Cancer 2014; 53: 15-24.
4. Agaram NP, LeLoarer FV, Zhang L, et al. USP6 gene rearrangements occur preferentially in giant cell reparative granulomas of the hands and feet but not in gnathic location. Hum Pathol 2014; 45: 1147-1152.
5. Oliveira AM, Hsi BL, Weremowicz S, et al. USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst. Cancer Res 2004; 64: 1920-1923.
6. Oliveira AM, Perez-Atayde AR, Inwards CY, et al. USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts. Am J Pathol 2004; 165: 1773-1780.
7. West RB, Rubin BP, Miller MA, et al. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci USA 2006; 103: 690-695.
8. Amary MF, Bacsi K, Maggiani F, et al. IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J Pathol 2011; 224: 334-343.
9. Kato Kaneko M, Liu X, Oki H, et al. Isocitrate dehydrogenase mutation is frequently observed in giant cell tumor of bone. Cancer Sci 2014; 105: 744-748.
10. Barnes L, Eveson JW, Reichart P, et al. World Health Organization Classification of Tumours: Pathology and Genetics of Head and Neck Tumours. IARC Press: Lyon, France, 2005.
11. Fletcher CDM, Bridge JA, Hogendoorn PCW, et al. (eds) WHO Classification of Tumours of Soft Tissue and Bone. IARC Press: Lyon, France, 2013.
12. Behjati S, Tarpey PS, Sheldon H, et al. Recurrent PTPRB and PLCG1 mutations in angiosarcoma. Nat Genet 2014; 46: 376-379.
13. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25: 1754-1760.
14. Thorvaldsdottir H, Robinson JT, Mesirov JP. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 2013; 14: 178-192.
15. Siebenrock KA, Unni KK, Rock MG. Giant-cell tumour of bone metastasising to the lungs. A long-term follow-up. J Bone Joint Surg Br 1998; 80: 43-47.
16. Ballester LY, Wang Z, Shandilya S, et al. Morphologic characteristics and immunohistochemical profile of diffuse intrinsic pontine gliomas. Am J Surg Pathol 2013; 37: 1357-1364.
17. Schwartzentruber J, Korshunov A, Liu XY, et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 2012; 482: 226-231.
18. Lewis PW, Muller MM, Koletsky MS, et al. Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 2013; 340: 857-861.
19. Chan KM, Fang D, Gan H, et al. The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression. Genes Dev 2013; 27: 985-990.
20. Rohle D, Popovici-Muller J, Palaskas N, et al. An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells. Science 2013; 340: 626-630.
21. Wang F, Travins J, DeLaBarre B, et al. Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation. Science 2013; 340: 622-626.
22. Amary MF, Ye H, Berisha F, et al. Detection of USP6 gene rearrangement in nodular fasciitis: an important diagnostic tool. Virchows Arch 2013; 463: 97-98.
23. Oliveira AM, Chou MM. USP6-induced neoplasms: the biologic spectrum of aneurysmal bone cyst and nodular fasciitis. Hum Pathol 2014; 45: 1-11.
24. Reichenberg EJ, Flanagan AM. Cherubism. In WHO Classification of Tumours of Soft Tissue and Bone, Fletcher CDM, Bridge JA, Hogendoorn PCW, et al. (eds). IARC Press: Lyon, France, 2013; 374.
25. Flanagan AM, Tirabosco R, Panagiotis DG. Osteoclast-rich lesions of bone: a clinical and molecular view. In Bone Cancer Progression and Therapeutic Approaches, (2nd edn) Heymann D (ed). Academic Press, Elsevier Inc., USA. 2015; 257-272.
26. Nord KH, Lilljebjorn H, Vezzi F, et al. GRM1 is upregulated through gene fusion and promoter swapping in chondromyxoid fibroma. Nat Genet 2014; 46: 474-477.
27. Van Loo P, Nordgard SH, Lingjaerde OC, et al. Allele-specific copy number analysis of tumors. Proc Natl Acad Sci U S A 2010; 107: 16910-16915.